What is the equivalent daily dosage of hydromorphone (opioid analgesic) to 40mg of oxycodone (opioid analgesic) daily?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hydromorphone Equivalent Dose for 40mg Daily Oxycodone

For a patient taking 40mg of oral oxycodone daily, the equivalent dose of oral hydromorphone is approximately 7.5 mg daily, which should be reduced by 25-50% to 3.75-5.6 mg daily (typically rounded to 4-6 mg daily in divided doses) when converting between opioids to account for incomplete cross-tolerance. 1

Calculation Method

Step 1: Convert Oxycodone to Morphine Equivalents

  • Oxycodone 40 mg/day × 1.5 (conversion factor) = 60 MME (morphine milligram equivalents) per day 1, 2
  • The CDC establishes a conversion factor of 1.5 for oxycodone to morphine equivalents 1, 2

Step 2: Convert Morphine Equivalents to Hydromorphone

  • Using the conversion table: 60 mg oral morphine = 7.5 mg oral hydromorphone 1
  • The CDC conversion factor for hydromorphone is 5.0, meaning hydromorphone is 5 times more potent than morphine 1
  • Therefore: 60 MME ÷ 5.0 = 12 mg hydromorphone would be the calculated equianalgesic dose

However, there is a critical discrepancy in the guideline conversion tables that must be addressed:

Reconciling the Conversion Data

  • The NCCN fentanyl conversion table indicates that 60 mg oral oxycodone = 15 mg oral hydromorphone 1
  • This suggests a direct oxycodone to hydromorphone ratio of approximately 4:1 (oral to oral)
  • Using this ratio: 40 mg oxycodone ÷ 4 = 10 mg oral hydromorphone as the calculated equianalgesic dose

Recommended Starting Dose

The safest approach is to start with 5-7.5 mg oral hydromorphone daily (50-75% dose reduction from calculated equianalgesic dose), divided into doses every 4-6 hours. 1

Dosing Schedule Options:

  • Conservative approach: 1 mg every 4 hours (6 mg/day total) 1
  • Moderate approach: 1.5 mg every 4 hours (9 mg/day total) - only if pain was poorly controlled on oxycodone 1
  • Provide immediate-release hydromorphone 0.5-1 mg every 2-4 hours as needed for breakthrough pain 1

Critical Safety Considerations

Mandatory Dose Reduction When Converting

  • Always reduce the calculated equianalgesic dose by 25-50% when rotating between opioids to account for incomplete cross-tolerance and individual pharmacokinetic variability 1
  • If the patient's pain was well-controlled on oxycodone 40 mg/day, use a 50% reduction (start with 5 mg hydromorphone/day) 1
  • If pain was poorly controlled, may use only a 25% reduction or start at full equianalgesic dose, but monitor closely 1

Important Caveats

  • Conversion factors are estimates only and cannot account for individual variability in genetics and pharmacokinetics 1, 2
  • Never use calculated MME doses directly when converting between opioids - the new opioid must be dosed substantially lower than the calculated dose 1, 2
  • Hydromorphone has a shorter duration of action (4-6 hours) compared to extended-release oxycodone formulations 1

Special Population Warning

  • Avoid hydromorphone (and morphine) in patients with renal failure due to accumulation of renally cleared metabolites that can cause neurotoxicity 1, 2

Monitoring and Titration

  • Reassess pain control and side effects within 24-48 hours of conversion 3
  • Titrate upward based on breakthrough medication requirements 3
  • Monitor closely for signs of oversedation or respiratory depression, especially in the first 24-72 hours 1
  • The peak respiratory depressant effect may occur at different times than peak analgesic effect 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Conversión de Oxicodona a Morfina

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Equivalencia de Dosis entre Oxicodona y Morfina

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.